Advanced Viral Research (ADVR) Inactive 10-Q2007 Q1 Quarterly report

Filed: 15 May 07, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: adjusted, ancillary, attached, average, began, behalf, beneficial, beneficially, blank, Bloomberg, calculated, carefully, Certificate, Certification, cessation, check, classification, comprised, consecutive, consideration, conversion, copy, counting, customary, debenture, declared, deferred, detail, discount, duly, enterprise, exemption, Exhibit, face, fail, failure, feature, FIN, guidance, hereof, impact, implementation, instrument, interpretation, lesser, loan, lowest, measurement, measuring, minimize, mutually, nonstatutory, opening, ownership, palliative, partial, partner, Placement, preferred, priority, promulgated, proxy, QUALITATIVE, QUANTITATIVE, quoted, receipt, redeem, redeemed, Regulation, reliance, relied, repay, resale, restricted, return, Rule, satisfaction, SEC, site, spray, structuring, terminology, thereof, thereunto, therewith, threshold, undersigned, Unregistered, update, urged, volume, waive, warrant, Yorkville

Removed: alternative, analyzed, APB, appointed, assessing, authority, authorization, basic, behavior, biopharmaceutical, cancellation, cancelled, capitalized, Carol, Chairman, charge, choice, chose, compare, confidentiality, contract, defined, designee, diluted, director, Dr, eligible, Epstein, estimated, exceeded, expensing, extended, FAS, forma, free, generating, guide, hand, highly, historical, historically, hour, impairment, initial, involved, issue, lack, large, leasehold, longer, Master, MD, Medical, method, modified, obtainable, ongoing, preparation, pricing, pro, project, prospective, readily, record, reduction, remain, requested, requirement, requisite, revised, revision, stockholder, subsequently, Treasury, valuation, vest, writing

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ADVR similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Advanced Viral Research Corp. (the “Company”) on Form 10-Q for the quarter ended March 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, the undersigned, certify, pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)		The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

	(2)		The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: May 14, 2007	/s/ Stephen M. Elliston
	Stephen M. Elliston President and Chief Executive Officer